Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications

Area of Science:

• Immunology and Regenerative Medicine
• Cell Biology and Therapeutics

Background:

• Mesenchymal stromal cells (MSCs) are multipotent progenitor cells with immunomodulatory capabilities.
• MSCs interact with various immune cells, including T, B, dendritic, and natural killer cells.

Purpose of the Study:

• To review the biological properties and immunosuppressive effects of MSCs.
• To elucidate the role of MSCs in the inflammatory microenvironment for therapeutic applications.
• To summarize MSCs' use in preclinical and clinical studies for autoimmune and other diseases.

Main Methods:

• Literature review of current knowledge on MSCs.
• Analysis of MSCs' interaction with immune cells and soluble factors.
• Summary of preclinical and clinical studies involving MSCs.

Main Results:

• MSCs exhibit unique biological properties and potent immunosuppressive effects on immune-competent cells.
• Soluble factors secreted by MSCs play a significant paracrine role in immunomodulation.
• MSCs have demonstrated potential in treating various diseases, including autoimmune conditions.

Conclusions:

• Understanding MSCs' interaction with the inflammatory microenvironment is crucial for optimizing their therapeutic efficacy.
• Further research into MSCs' mechanisms and challenges is needed for successful clinical translation in cell therapies.